Source-control Adjunctive Therapy

Source-Control Adjunctive Therapy is a therapeutic intervention, belonging to the class of adjunctive treatments in sepsis management, that specifically complements primary source control by targeting microbial persistence, tissue damage, or immune dysregulation at the anatomical site of infection to improve clinical outcomes.

2

Publications

79

Citations

6

Authors

3

Institutions

Publications per year

2017–2026

0

Authors

6

  1. JM
    John M.A. Bohnen

    University of Toronto, Canada

    1 publications · 17 citations

    1

    h-index

  2. DE
    Donald E. Fry

    University of New Mexico, United States

    1 publications · 17 citations

    1

    h-index

  3. JS
    Joseph S. Solomkin

    University of Cincinnati Medical Center, United States

    1 publications · 17 citations

    1

    h-index

  4. JC
    John C. Marshall

    University of Toronto, Canada

    1 publications · 62 citations

    1

    h-index

  5. SB
    Sara B. Johnson

    Johns Hopkins University, United States

    1 publications · 17 citations

    1

    h-index

1–5 of 6

Institutions

3

  1. St. Michael's Hospital

    Toronto, Canada

    1 h-index

    1 publications

    62 citations

  2. University of Toronto

    Toronto, Canada

    1 h-index

    1 publications

    17 citations

  3. St Michael's Hospital

    Braintree, United Kingdom

    1 h-index

    1 publications

    62 citations

1–3 of 3

Venues

  1. Current Infectious Disease Reports

    1 publications · 62 citations

    1

    h-index

  2. PubMed

    Repository · 1 publications · 17 citations

    1

    h-index

1–2